Ponni Sugars (Erode) Limited (PONNIERODE) fundamentals
Ponni Sugars (Erode) Limited is a listed company in Agricultural Food & other Products, part of the Fast Moving Consumer Goods sector, listed on the NSE as PONNIERODE (ISIN INE838E01017). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Ponni Sugars (Erode) Limited does
Ponni Sugars (Erode) Limited is an India-based producer of sugar. The Company operates through two segments: Sugar and Cogeneration of power (Cogen). It has a sugar factory in Erode that can crush up to 3500 tons of sugarcane per day and generate approximately 19 megawatts (MW) of power. Its products include sugar, bagasse, molasses and power. The Company's plant is located in Odapalli, Cauvery RSPO, Namakkal District, Tamil Nadu.
Valuation and market data
| Last close | ₹371.10 |
|---|---|
| Market capitalisation | ₹319 crore |
| Enterprise value | ₹364 crore |
| P/E (TTM) | 6.64 |
| Price to book | 0.56 |
| Price to sales (TTM) | 0.41 |
| Book value per share | ₹660.62 |
| Dividend yield | 134.73% |
| Sector | Fast Moving Consumer Goods |
| Industry | Agricultural Food & other Products |
| Listed since | Tue Apr 16 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹429 crore | ₹90 crore | ₹48 crore | 55.85 |
| Mar 2025 | ₹371 crore | ₹28 crore | ₹19 crore | 22.42 |
| Mar 2024 | ₹439 crore | ₹52 crore | ₹47 crore | 54.49 |
| Mar 2023 | ₹450 crore | ₹48 crore | ₹38 crore | 44.58 |
Figures are as reported (standalone), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 47.3% |
|---|---|
| Foreign institutions (FII) | 9.5% |
| Mutual funds | 0.1% |
| Other domestic institutions | 0.0% |
| Retail and others | 43.1% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.